Change Password

Please Enter Your Email ID

Email ID

Email ID doesn't exist
We regret to inform that your user details could not be verified and your registration is unsuccessful.
Something went wrong please try again
Email ID is Required

Repatha^® (evolocumab) is subject to additional monitoring. Adverse events should be reported. Reporting forms and information can be found:

Adverse events should also be reported to Amgen Limited on:

+44 (0) 1223 436 441

If you think there may be a defect or quality issue with the Amgen product you have received, please provide us with the details via phone call:

+44 (0) 1223 436 441

×